HLA
Hamilton Lane Advisors’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,657
| Closed | -$596K | – | 19 |
|
|
2024
Q2 | $596K | Buy |
+25,657
| New | +$596K | 0.48% | 15 |
|
|
2023
Q3 | – | Sell |
-52,129
| Closed | -$1.54M | – | 35 |
|
|
2023
Q2 | $1.54M | Buy |
+52,129
| New | +$1.54M | 0.68% | 27 |
|
|
2021
Q4 | – | Sell |
-396,944
| Closed | -$20M | – | 91 |
|
|
2021
Q3 | $20M | Buy |
+396,944
| New | +$20M | 3.36% | 6 |
|
|
2021
Q2 | – | Sell |
-97,370
| Closed | -$5.56M | – | 82 |
|
|
2021
Q1 | $5.56M | Buy |
+97,370
| New | +$5.56M | 1.81% | 12 |
|
|
2019
Q4 | – | Sell |
-30,948
| Closed | -$474K | – | 49 |
|
|
2019
Q3 | $474K | Buy |
+30,948
| New | +$474K | 0.2% | 39 |
|